Clinical Trial Update: Early Treatment Diabetic Retinopathy Study (ETDRS) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the Early Treatment Diabetic Retinopathy Study (ETDRS); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blindness
• Diabetic Retinopathy

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Blindness, Diabetic Retinopathy | Phase 3 | Status: COMPLETED